跳至主要内容
临床试验/NCT01250405
NCT01250405已完成4 期

Acute Effects of Cinacalcet on Arterial Stiffness and Ventricular Function in Hemodialysis Patients

Laval University1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2012年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
23
试验地点
1
主要终点
Arterial stiffness

研究概览

简要总结

The primary objective is to determine whether reduction of serum calcium concentration by cinacalcet leads to reduction of mean blood pressure adjusted c-fPWV. The secondary objectives are to study the effects of calcium reduction on 1) carotid-radial PWV (c-rPWV), 2) common carotid artery (CCA) biomechanics, 3) pulse wave profile and cardiac function.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • chronic (> 3 months) hemodialysis population of > 18 years old
  • PTH > 300 ng/L
  • corrected Ca > 2.10 mmol/L
  • stable hypertensive drugs (> 1 month)
  • stable doses of phosphate binders and dialysis calcium concentration
  • palpable femoral pulse
  • systolic BP of 90-180 mmHg
  • expected survival of > 6 months

排除标准

  • hemodialysis > 3 years
  • acute infection
  • history of myocardial infarction or stroke within the past 3 months
  • inability to consent
  • intolerance to cinacalcet
  • inadequate birth control

研究组 & 干预措施

Cinacalcet

Active Comparator

干预措施: Cinacalcet (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Arterial stiffness

时间窗: Arterial stiffness with be measured after 1 week with placebo and after 1 week with cinacalcet

次要结局

  • Ventricular function(Ventricular function with be measured after 1 week with placebo and after 1 week with cinacalcet)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karine Marquis

Professionnelle de recherche

Laval University

研究点 (1)

Loading locations...

相似试验